Go to
JCI Insight
Citations to this article
A M Scanu, G M Fless
Published June 1, 1990
Citation Information: J Clin Invest. 1990;85(6):1709-1715. https://doi.org/10.1172/JCI114625.
Citation Information: J Clin Invest. 1990;85(6):1709-1715. https://doi.org/10.1172/JCI114625.
Total citations by year
Citation information
Citations to this article (459)
| Title and authors | Publication | Year |
|---|---|---|
|
The indicative effects of apolipoproteins on organic erectile dysfunction: bridging Mendelian randomization and case-control study
Zhang Z, Yan M, Li Y, Pan Y, Wang S, Xu M, Zhou H, Liu X |
Frontiers in Endocrinology | 2024 |
|
N-Acetylcysteine and Atherosclerosis: Promises and Challenges
Cui Y, Zhu Q, Hao H, Flaker GC, Liu Z |
Antioxidants | 2023 |
|
Crosstalk between neurological, cardiovascular, and lifestyle disorders: insulin and lipoproteins in the lead role.
Tyagi R, Vaidya B, Sharma SS |
Pharmacological reports : PR | 2022 |
|
Osteonecrosis of the Jaws in Patients with Hereditary Thrombophilia/Hypofibrinolysis-From Pathophysiology to Therapeutic Implications.
Badescu MC, Rezus E, Ciocoiu M, Badulescu OV, Butnariu LI, Popescu D, Bratoiu I, Rezus C |
International journal of molecular sciences | 2022 |
|
The Suggestive Effect of Apo A, Apo B, and Apo A/Apo B on Erectile Dysfunction
X Li, D Li |
The Journal of Sexual Medicine | 2021 |
|
The Evaluation of Serum Lipids Profile in Patients with Pemphigus Vulgaris: A Case-Control Study
Rezazadeh F, Moshaverinia M, Handjani F, Khoshkholgh F, Saki N, Heiran A |
The Malaysian Journal of Medical Sciences : MJMS | 2020 |
|
ASPC Manual of Preventive Cardiology
ND Wong, EA Amsterdam, PP Toth |
2020 | |
|
Laboratory medicine: health evaluation in elite athletes
B Lombardo, V Izzo, D Terracciano, A Ranieri, C Mazzaccara, F Fimiani, A Cesaro, L Gentile, E Leggiero, R Pero, B Izzo, AC DAlicandro, D Ercolini, G DAlicandro, G Frisso, L Pastore, P Calabrò, O Scudiero |
Clinical Chemistry and Laboratory Medicine | 2019 |
|
Statin treatment increases lipoprotein(a) levels in subjects with low molecular weight apolipoprotein(a) phenotype
R Yahya, K Berk, A Verhoeven, S Bos, L van der Zee, J Touw, G Erhart, F Kronenberg, R Timman, E Sijbrands, JR van Lennep, M Mulder |
Atherosclerosis | 2019 |
|
Individuals with familial hypercholesterolemia and cardiovascular events have higher circulating Lp(a) levels
C Pavanello, C Pirazzi, K Bjorkman, J Sandstedt, C Tarlarini, L Mosca, S Romeo, L Calabresi, RM Mancina |
Journal of Clinical Lipidology | 2019 |
|
Effect of diet-induced weight loss on lipoprotein(a) levels in obese individuals with and without type 2 diabetes
KA Berk, R Yahya, AJ Verhoeven, J Touw, FP Leijten, EF van Rossum, VL Wester, MA Lips, H Pijl, R Timman, G Erhart, F Kronenberg, JE van Lennep, EJ Sijbrands, MT Mulder |
Diabetologia | 2017 |
|
Reduction of cardiovascular risk in subjects with high lipoprotein (a) levels
G Malaguarnera, S Latteri, VE Catania, M Malaguarnera |
Journal of Thoracic Disease | 2017 |
|
Lipoprotein(a): A missing culprit in the management of athero-thrombosis?
G Ferretti, T Bacchetti, TP Johnston, M Banach, M Pirro, A Sahebkar |
Journal of Cellular Physiology | 2017 |
|
Interaction Between Vitamin D and Lipoprotein (a) on the Presence and Extent of Coronary Heart Disease
K Li, X Yang, L Wang, M Chen, L Xu, X Yang |
Heart, lung & circulation | 2017 |
|
Lipoprotein (a) as a cause of cardiovascular disease: insights from epidemiology, genetics, and biology
BG Nordestgaard, A Langsted |
Journal of lipid research | 2016 |
|
Lipoprotein(a) in patients with hepatocellular carcinoma and portal vein thrombosis
G Malaguarnera, VE Catania, A Francaviglia, M Malaguarnera, F Drago, M Motta, S Latteri |
Aging clinical and experimental research | 2016 |
|
Lipoprotein(a) – An independent causal risk factor for cardiovascular disease and current therapeutic options
U Kassner, T Schlabs, A Rosada, E Steinhagen-Thiessen |
Atherosclerosis Supplements | 2015 |
|
The application of multiple reaction monitoring and multi-analyte profiling to HDL proteins
HN Yassine, AM Jackson, CR Borges, D Billheimer, H Koh, D Smith, P Reaven, SS Lau, CH Borchers |
Lipids in Health and Disease | 2014 |
|
Oxidized low-density lipoprotein as a biomarker of cardiovascular diseases
A Trpkovic, I Resanovic, J Stanimirovic, D Radak, SA Mousa, D Cenic-Milosevic, D Jevremovic, ER Isenovic |
Critical Reviews in Clinical Laboratory Sciences | 2014 |
|
Reduction in Lipoprotein(a) With PCSK9 Monoclonal Antibody Evolocumab (AMG 145)
FJ Raal, RP Giugliano, MS Sabatine, MJ Koren, G Langslet, H Bays, D Blom, M Eriksson, R Dent, SM Wasserman, F Huang, A Xue, M Albizem, R Scott, EA Stein |
Journal of the American College of Cardiology | 2014 |
|
Therapeutic Vaccines for Hypertension and Dyslipidemia
H Nakagami, H Koriyama, R Morishita |
International Heart Journal | 2014 |
|
Review of lipid and lipoprotein(a) abnormalities in childhood arterial ischemic stroke: Review
SM Sultan, N Schupf, MM Dowling, GA DeVeber, A Kirton, MS Elkind |
International Journal of Stroke | 2013 |
|
Inhibition of neointima formation through DNA vaccination for apolipoprotein(a): a new therapeutic strategy for lipoprotein(a)
M Kyutoku, H Nakagami, H Koriyama, F Nakagami, M Shimamura, H Kurinami, H Tomioka, T Miyake, T Katsuya, R Morishita |
Scientific Reports | 2013 |
|
A Systematic Literature Review of the Association of Lipoprotein(a) and Autoimmune Diseases and Atherosclerosis
I Missala, U Kassner, E Steinhagen-Thiessen |
International Journal of Rheumatology | 2012 |
|
LDL-Apheresis: Technical and Clinical Aspects
R Bambauer, C Bambauer, B Lehmann, R Latza, R Schiel |
The Scientific World JOURNAL | 2012 |
|
Methods in Enzymology
JD Stone, AS Chervin, DH Aggen, DM Kranz |
Protein Engineering for Therapeutics Part B | 2012 |
|
Tocotrienols: Vitamin E Beyond Tocopherols, Second Edition
W Weng-Yew, L Brown |
Tocotrienols: Vitamin E Beyond Tocopherols, Second Edition | 2012 |
|
Oxidized phospholipids modify plasminogen and apolipoprotein(a): Implications for vascular disease
AM Scanu, DM Stafforini, C Edelstein |
American Journal of Molecular Biology | 2012 |
|
Advances in Clinical Chemistry
M Mahler |
Advances in Clinical Chemistry Volume 54 | 2011 |
|
Multifaceted role of tocotrienols in cardioprotection supports their structure: function relation
HR Vasanthi, RP Parameswari, DK Das |
Genes & Nutrition | 2011 |
|
Lipoprotein(a)-cholesterol: A significant component of serum cholesterol
K Kinpara, H Okada, A Yoneyama, M Okubo, T Murase |
Clinica Chimica Acta | 2011 |
|
Annual Reports in Medicinal Chemistry
JJ Liu, TW Lee |
Annual Reports in Medicinal Chemistry Volume 46 | 2011 |
|
Enigmatic Role of Lipoprotein(a) in Cardiovascular Disease
E Anuurad, B Enkhmaa, L Berglund |
Clinical and Translational Science | 2010 |
|
Angiogenesis
TH Adair, JP Montani |
Colloquium Series on Integrated Systems Physiology: From Molecule to Function | 2010 |
|
Serum Lipoprotein (a) Levels in Patients with First Unprovoked Venous Thromboembolism is not Associated with Subsequent Risk of Recurrent VTE
MA Rodger, GL Gal, M Carrier, MT Betancourt, SR Kahn, PS Wells, DA Anderson, K Lacut, I Chagnon, S Solymoss, M Crowther, A Perrier, R White, L Vickars, T Ramsay, MJ Kovacs |
Thrombosis Research | 2010 |
|
Behçet’s Disease as a Model of Venous Thrombosis
ML Regina, AY Gasparyan, F Orlandini, D Prisco |
The open cardiovascular medicine journal | 2010 |
|
Changes in lipoprotein(a), oxidized phospholipids, and LDL subclasses with a low-fat high-carbohydrate diet
N Faghihnia, S Tsimikas, ER Miller, JL Witztum, RM Krauss |
Journal of lipid research | 2010 |
|
Atlas of Atherosclerosis and Metabolic Syndrome
SM Grundy |
2010 | |
|
Pulmonary surfactant: an immunological perspective
ZC Chroneos, Z Sever-Chroneos, VL Shepherd |
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology | 2009 |
|
The oxidized phospholipids linked to human apolipoprotein(a) do not derive from circulating low-density lipoproteins and are probably of cellular origin
C Edelstein, B Philips, D Pfaffinger, AM Scanu |
The FASEB Journal | 2009 |
|
Lipoprotein (a) in patients with psoriasis: associations with lipid profiles and disease severity
A Pietrzak, J Kądzielewski, K Janowski, J Roliński, D Krasowska, G Chodorowska, T Paszkowski, E Kapeć, I Jastrzębska, J Tabarkiewicz, T Lotti |
International Journal of Dermatology | 2009 |
|
Homocysteine and lipoprotein (a) correlation in ischemic stroke patients
RK Dhamija, P Gaba, S Arora, A Kaintura, M Kumar, J Bhattacharjee |
Journal of the Neurological Sciences | 2009 |
|
Risk factors for cardiovascular disease in Sardinia from 1978 to 2001: A comparative study with Italian mainland
S Muntoni, L Atzori, R Mereu, A Manca, G Satta, A Gentilini, P Bianco, A Baule, GM Baule, S Muntoni |
European Journal of Internal Medicine | 2009 |
|
Klinische Kardiologie
E Erdmann |
2009 | |
|
Biochemistry of Lipids, Lipoproteins and Membranes
JE Vance, K Adeli |
Biochemistry of Lipids, Lipoproteins and Membranes | 2008 |
|
Impact of elevated serum lipoprotein (a) concentrations on the risk of coronary heart disease in patients with type 2 diabetes mellitus
T Murase, M Okubo, M Amemiya-Kudo, T Ebara, Y Mori |
Metabolism | 2008 |
|
Hemostatic and Inflammatory Risk Factors for Intracerebral Hemorrhage in a Pooled Cohort
JD Sturgeon, AR Folsom, WT Longstreth, E Shahar, WD Rosamond, M Cushman |
Stroke; a journal of cerebral circulation | 2008 |
|
Apheresis in Coronary Heart Disease With Elevated Lp (a): A Review of Lp (a) As a Risk Factor and Its Management
C Keller |
Therapeutic Apheresis and Dialysis | 2007 |
|
LPA +93C>T and +121G>A polymorphisms detection by electronic microchip technology
E Sticchi, M Lenti, B Giusti, I Sestini, R Abbate, C Fatini |
Molecular Genetics and Metabolism | 2007 |
|
Impact of markedly elevated serum lipoprotein(a) levels (≥100 mg/dL) on the risk of coronary heart disease
T Murase, M Okubo, M Amemiya-Kudo, T Hiraga, J Oka, M Shimada, T Igarashi |
Metabolism | 2007 |
|
Increased plasma concentrations of lipoprotein(a) during a low-fat, high-carbohydrate diet are associated with increased plasma concentrations of apolipoprotein C-III bound to apolipoprotein B–containing lipoproteins
MJ Shin, PJ Blanche, RS Rawlings, HS Fernstrom, RM Krauss |
The American journal of clinical nutrition | 2007 |
|
Serum lipoprotein (a) levels in patients with diabetic foot lesions
K Ünlühızarcı, S Muhtaroğlu, Ş Kabak, F Bayram, F Keleştimur |
Diabetes Research and Clinical Practice | 2006 |
|
The effect of continuous combined HRT on glucose homeostasis and plasma lipids
L Thunell, B Andersson, M Glassell, LÅ Mattsson |
Maturitas | 2006 |
|
Lipoprotein(a): A Unique Risk Factor for Cardiovascular Disease
E Anuurad, MB Boffa, ML Koschinsky, L Berglund |
Clinics in Laboratory Medicine | 2006 |
|
Recent developments in the treatment of atherosclerosis: Review article
PS Brahmkshatriya, MH Jani, MT Chhabria |
Journal of Enzyme Inhibition and Medicinal Chemistry | 2006 |
|
Is Lipoprotein (a)-Apheresis Useful?
R Bambauer |
Therapeutic Apheresis and Dialysis | 2005 |
|
Plasma homocysteine and lipoprotein (a) levels in Turkish patients with metabolic syndrome
A Guven, F Inanc, M Kilinc, H Ekerbicer |
Heart and Vessels | 2005 |
|
New risk factors for atherosclerosis in hypertension: focus on the prothrombotic state and lipoprotein(a)
C Catena, M Novello, R Lapenna, S Baroselli, G Colussi, E Nadalini, G Favret, A Cavarape, G Soardo, LA Sechi |
Journal of Hypertension | 2005 |
|
Role of candidate genes in the lipid responses to intensified treatment in Type 2 diabetes
O Ukkola, J Salonen, YA Kesäniemi |
Journal of Endocrinological Investigation | 2005 |
|
Elements in the C terminus of apolipoprotein [a] responsible for the binding to the tenth type III module of human fibronectin
C Edelstein, M Yousef, AM Scanu |
Journal of lipid research | 2005 |
|
Apolipoprotein B and apolipoprotein A-I: risk indicators of coronary heart disease and targets for lipid-modifying therapy
G Walldius, I Jungner |
Journal of Internal Medicine | 2004 |
|
A proximal tissue-specific module and a distal negative regulatory module control apolipoprotein(a) gene transcription
S Negi, SK Singh, N Pati, V Handa, R Chauhan, U Pati |
Biochemical Journal | 2004 |
|
El fenotipo de lipoproteína(a): ¿un marcador genético de enfermedad coronaria?
JJ Gómez-Barrado, S Turégano, JC García-Rubira, JM Cruz |
Clínica e Investigación en Arteriosclerosis | 2004 |
|
Abnormal in vivo metabolism of apoB-containing lipoproteins in human apoE deficiency
K Ikewaki, W Cain, F Thomas, R Shamburek, LA Zech, D Usher, HB Brewer, DJ Rader |
Journal of lipid research | 2004 |
|
Study of Apo(a) Length Polymorphism and Lipoprotein(a) Concentrations in Subjects with Single or Double Apo(a) Isoforms
M Alaoui, C Merle, R Garnotel, D Jolly, V Durlach, P Gillery |
Clinical Chemistry and Laboratory Medicine | 2003 |
|
Insulin sensitivity and Lp(alpha) concentrations in normoglycemic offspring of type 2 diabetic parents
A Psyrogiannis, I Habeos, V Kyriazopoulou |
Lipids in Health and Disease | 2003 |
|
Lung Biology in Health and Disease
N Zamel |
Lung Biology in Health and Disease: Experimental Models and Therapeutic Potential | 2003 |
|
Relationship between apolipoprotein(a) size polymorphism and coronary heart disease in overweight subjects
E Emanuele, E Peros, P Minoretti, C Falcone, A D'Angelo, L Montagna, D Geroldi |
BMC Cardiovascular Disorders | 2003 |
|
Lack of genetic linkage evidence for a trans -acting factor having a large effect on plasma lipoprotein[a] levels in African Americans
RA Barkley, AC Brown, CL Hanis, SL Kardia, ST Turner, E Boerwinkle |
Journal of lipid research | 2003 |
|
Factors contributing to variation in lipoprotein (a) in Melbourne Anglo-Celtic population
ZW Xiong, ML Wahlqvist, NT Wattanapenpaiboon, BM Biegler, ND Balazs, DW Xiong, YL Lim |
European Journal of Clinical Nutrition | 2003 |
|
Prediction of Short-Term Progression or Regression of Atherosclerotic Coronary Artery Disease by Lipoprotein (a): A Quantitative Coronary Angiographic Study
T Uchida, T Inoue, H Kamishirado, K Takayanagi, S Morooka |
Angiology | 2003 |
|
Atlas of Atherosclerosis
PW Wilson |
2003 | |
|
Lipoprotein(a) and cardiovascular risk factors in a cohort of 6-year-old children. The Rivas-Vaciamadrid Study
A Gonzalez-Requejo, M Sanchez-Bayle, C Ruiz-Jarabo, J Asensio-Anton, MJ Pelaez, MT Morales, E Anton-Pacheco, M Fernandez-Calle, E Madera-Cruz |
European Journal of Pediatrics | 2003 |
|
Hormonal influences on lipoprotein(a) metabolism
RW Pang, KS Lam |
Diabetes, Obesity and Metabolism | 2002 |
|
Issues concerning the monitoring of statin therapy in hypercholesterolemic subjects with high plasma lipoprotein (a) levels
AM Scanu, J Hinman |
Lipids | 2002 |
|
Low-Density Lipoprotein Apheresis: Clinical Results with Different Methods
R Bambauer |
Artificial Organs | 2002 |
|
Premature Lower Extremity Atherosclerosis:
PJ Levy |
The American Journal of the Medical Sciences | 2002 |
|
Lipid profile during rhGH therapy in pediatric renal transplant patients
L Ghio, B Damiani, R Garavaglia, G Oppizzi, E Taioli, A Edefonti |
Pediatric Transplantation | 2002 |
|
An ELISA Procedure for Human Lp(a) Quantitation Using Monoclonal Antibodies
P Bustos, M Muñoz, N Ulloa, P Godoy, C Calvo |
Hybridoma and Hybridomics | 2002 |
|
Interaction of oestrogen and peroxisome proliferator-activated receptors with apolipoprotein(a) gene enhancers
LH Puckey, BL Knight |
Biochemical Journal | 2002 |
|
Serum Lp(a) in diabetics with and without evidence of clinical nephropathy-A preliminary study
SJ Kumari, N Jayaram, L Vincent, T Venkatesh |
Indian Journal of Clinical Biochemistry | 2002 |
|
Comorbidity and Cardiovascular Risk Factors in Patients With Chronic Kidney Disease
J Paparello, A Kshirsagar, D Batlle |
Seminars in Nephrology | 2002 |
|
Determinants of Progression of Coronary Artery Calcifications in Asymptomatic Men at High Cardiovascular Risk
G Chironi, A Simon, N Denarié, B Védie, V Séné, J Mégnien, J Levenson |
Angiology | 2002 |
|
Pan Vascular Medicine
P Lanzer, EJ Topol |
2002 | |
|
Elevated lipoprotein(a) concentration is an independent risk factor of venous thromboembolism
U Nowak-Göttl, R Schobess, K Kurnik, D Schwabe, G Fleischhack, R Junker |
Blood | 2002 |
|
The role of lipoprotein(a) in the pathogenesis of atherosclerotic cardiovascular disease and its utility as predictor of coronary heart disease events
AM Scanu |
Current Cardiology Reports | 2001 |
|
Journal of Cardiovascular Risk
S Kumbasar, I Dincer, F Ertas, S Gulec, C Erol, O Akyurek, M Kilickap, D Oral, E Sipahi, Y Laleli |
Journal of Cardiovascular Risk | 2001 |
|
Monogenic Dyslipidemias: Window on Determinants of Plasma Lipoprotein Metabolism
RA Hegele |
The American Journal of Human Genetics | 2001 |
|
Current Topics on Low-Density Lipoprotein Apheresis
R Bambauer, R Schiel, R Latza |
Therapeutic Apheresis and Dialysis | 2001 |
|
Prospective association of lipoprotein(a) concentrations and apo(a) size with coronary heart disease among men in the Multiple Risk Factor Intervention Trial
RW Evans, O Shpilberg, BJ Shaten, S Ali, MI Kamboh, LH Kuller |
Journal of Clinical Epidemiology | 2001 |
|
HRT in women with diabetes—review of the effects on glucose and lipid metabolism
SL Palin, S Kumar, DW Sturdee, AH Barnett |
Diabetes Research and Clinical Practice | 2001 |
|
Atherosclerosis and Autoimmunity
EC Lau |
Atherosclerosis and Autoimmunity | 2001 |
|
Relationship of lipoprotein(a) to variables of coagulation in hypertensive subjects
L A Sechi, S De Marchi |
Journal of Investigative Medicine | 2001 |
|
Atherosclerosis and autoimmunity
PA Gordon, J George, MA Khamashta, D Harats, G Hughes, Y Shoenfeld |
Lupus | 2001 |
|
Impact of Apolipoprotein(a) Phenotypes on Long-Term Renal Transplant Survival
F Wahn, V Daniel, F Kronenberg, G Opelz, DV Michalk, U Querfeld |
Journal of the American Society of Nephrology : JASN | 2001 |
|
Oxidative events cause degradation of apoB-100 but not of apo[a] and facilitate enzymatic cleavage of both proteins
C Edelstein, K Nakajima, D Pfaffinger, AM Scanu |
Journal of lipid research | 2001 |
|
Hypercholesterolemia and dyslipidemia
HR Superko |
Current Treatment Options in Cardiovascular Medicine | 2000 |
|
GENETICS OFLIPOPROTEINABNORMALITIESASSOCIATED WITHCORONARYHEARTDISEASESUSCEPTIBILITY
JL Breslow |
Annual Review of Genetics | 2000 |
|
Lipoprotein (a), haemostatic variables and cardiovascular damage in hypertensive patients
LA Sechi, C Catena, D Casaccio, L Zingaro |
Journal of Hypertension | 2000 |
|
Cytokine Release and Serum Lipoprotein (a) Alterations During Hemodialysis
HA Tzanatos, B Agroyannis, C Chondros, A Kapetanaki, C Fourtounas, L Soubassi, I Kopelias |
Artificial Organs | 2000 |
|
Are lipid-dependent indicators of cardiovascular risk affected by renal transplantation?
A Schena, SD Paolo, LF Morrone, F Resta, G Stallone, FP Schena |
Clinical Transplantation | 2000 |
|
Relation between lipoprotein (a) and in vitro oxidation of apolipoprotein B-containing lipoproteins
Z Serdar, E Sarandol, M Dirican, D Yesilbursa, A Serdar, A Tokullugil |
Clinical Biochemistry | 2000 |
|
Lipoprotein(a), Atherosclerosis, and Apolipoprotein(a) Gene Polymorphism
U Pati, N Pati |
Molecular Genetics and Metabolism | 2000 |
|
Relation between circadian patterns in levels of circulating lipoprotein(a), fibrinogen, platelets, and related lipid variables in men
WF Bremner, RB Sothern, EL Kanabrocki, M Ryan, JB McCormick, S Dawson, ES Connors, R Rothschild, JL Third, S Vahed, BM Nemchausky, P Shirazi, JH Olwin |
American Heart Journal | 2000 |
|
Changes in lipoprotein(a) concentration after orthotopic heart transplantation
D DeNofrio, S Desai, DJ Rader, G Chang, MP Kelley, MA Acker, E Loh |
American Heart Journal | 2000 |
|
Lipoprotein(a), tobacco use, and risk of coronary heart disease
M Serrano, J Irala, M Palacios |
International Journal of Cardiology | 2000 |
|
Distribution of serum apolipoproteins A-I and B and lipoprotein(a) in European elderly
JH Contois, AH Wu, Z Li, AH Feroze, F Grunenberger, J Haller, L deGroot, CJ Lammi-Keefe |
Clinica Chimica Acta | 2000 |
|
Lipoprotein(a) oxidation and autoantibodies: a new path in atherothrombosis
FI Romero, MA Khamashta, GR Hughes |
Lupus | 2000 |
|
Apo(a)-kringle IV-type 6: expression in Escherichia coli, purification and in vitro refolding
A Hrzenjak, S Frank, B Maderegger, H Sterk, GM Kostner |
Protein Engineering Design and Selection | 2000 |
|
Regulation of Intestinal Apolipoprotein B mRNA Editing Levels by a Zinc-Deficient Diet and cDNA Cloning of Editing Protein in Hamsters
SK Reaves, JY Wu, Y Wu, JC Fanzo, YR Wang, PP Lei, KY Lei |
The Journal of nutrition | 2000 |
|
Homocysteine and Lipoprotein(a) Interact to Increase CAD Risk in Young Men and Women
JA Foody, JA Milberg, K Robinson, GL Pearce, DW Jacobsen, DL Sprecher |
Arteriosclerosis, thrombosis, and vascular biology | 2000 |
|
Lipoprotein (a) metabolism estimated by nonsteady-state kinetics
KG Parhofer, T Demant, MM Ritter, HC Geiss, M Donner, P Schwandt |
Lipids | 1999 |
|
Lipoprotein(a)
HH Hobbs, AL White |
Current Opinion in Lipidology | 1999 |
|
Lipoprotein(a) and apolipoprotein(a) isoforms and proteinuria in patients with moderate renal failure
LA Sechi, L Zingaro, C Catena, A Perin, SD Marchi, E Bartoli |
Kidney International | 1999 |
|
Association between apolipoprotein(a) phenotypes and coronary heart disease at a young age
C Gazzaruso, A Garzaniti, P Buscaglia, G Bonetti, C Falcone, P Fratino, G Finardi, D Geroldi |
Journal of the American College of Cardiology | 1999 |
|
Atherogenecity of lipoprotein(a) and oxidized low density lipoprotein: insight from in vivo studies of arterial wall influx, degradation and efflux
LB Nielsen |
Atherosclerosis | 1999 |
|
Lipoprotein(a) and coronary thrombosis and restenosis after stent placement
A Wehinger, A Kastrati, S Elezi, H Baum, S Braun, FJ Neumann, A Schömig |
Journal of the American College of Cardiology | 1999 |
|
Plasma and Lp(a)-associated PAF-acetylhydrolase activity in uremic patients undergoing different dialysis procedures
HJ Milionis, MS Elisaf, SA Karabina, E Bairaktari, AD Tselepis, KC Siamopoulos |
Kidney International | 1999 |
|
The progressive nature of peripheral arterial disease in young adults: A prospective analysis of white men referred to a vascular surgery service
RJ Valentine, MR Jackson, JG Modrall, KE McIntyre, GP Clagett |
Journal of Vascular Surgery | 1999 |
|
Lipoprotein metabolism during normal pregnancy
P Brizzi, G Tonolo, F Esposito, L Puddu, S Dessole, M Maioli, S Milia |
American Journal of Obstetrics and Gynecology | 1999 |
|
Tocotrienol: a review of its therapeutic potential
A Theriault, JT Chao, Q Wang, A Gapor, K Adeli |
Clinical Biochemistry | 1999 |
|
Lipoproteins and the haemostatic system in atherothrombotic disorders
GJ Miller |
Best Practice & Research Clinical Haematology | 1999 |
|
Effect of tranexamic acid and delta-aminovaleric acid on lipoprotein(a) metabolism in transgenic mice
S Frank, A Hrzenjak, K Kostner, W Sattler, GM Kostner |
Biochimica et Biophysica Acta | 1999 |
|
6-Aminohexanoic acid as a chemical chaperone for apolipoprotein(a)
J Wang, AL White |
The Journal of biological chemistry | 1999 |
|
Genetic prediction of coronary heart disease: Lessons from Canada
RA Hegele |
Scandinavian Journal of Clinical & Laboratory Investigation | 1999 |
|
Postmenopausal hormone replacement, risk estimators for coronary artery disease and cardiovascular protection
V Mijatovic, MJ van der Mooren, CD Stehouwer, JC Netelenbos, P Kenemans |
Gynecological Endocrinology | 1999 |
|
Serum lipoprotein(a) profiles in a singaporean population
MS Wong, WL Chew, TC Aw |
Pathology | 1999 |
|
Cell and molecular biology of the assembly and secretion of apolipoprotein B-containing lipoproteins by the liver
RA Davis |
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids | 1999 |
|
Estrogen Modulation of Apolipoprotein(a) Expression: IDENTIFICATION OF A REGULATORY ELEMENT
D Boffelli, DA Zajchowski, Z Yang, RM Lawn |
The Journal of biological chemistry | 1999 |
|
Presecretory degradation of apolipoprotein[a] is mediated by the proteasome pathway
AL White, B Guerra, J Wang, RE Lanford |
Journal of lipid research | 1999 |
|
Effects of Exercise on Lipoprotein(a):
LT Mackinnon, LM Hubinger |
Sports Medicine | 1999 |
|
Endogenous formaldehyde as a potential factor of vulnerability of atherosclerosis: involvement of semicarbazide-sensitive amine oxidase-mediated methylamine turnover
PH Yu, YL Deng |
Atherosclerosis | 1998 |
|
Long-Term Variability of Serum Lipoprotein(a) Concentrations in Healthy Fertile Women
R Garnotel, F Monier, F Lefèvre, P Gillery |
Clinical Chemistry and Laboratory Medicine | 1998 |
|
Lipoprotein(a) Apheresis in Severe Coronary Heart Disease: an Immunoadsorption Method
H Ullrich, KJ Lackner, G Schmitz |
Artificial Organs | 1998 |
|
Effects of estrogen replacement therapy on the lipoprotein profile in postmenopausal women with ESRD
ES Ginsburg, B Walsh, L Greenberg, D Price, GM Chertow, WF Owen |
Kidney International | 1998 |
|
Detection of serum and urinary lipoprotein(a) in patients with renal diseases
JJ WANG, XD YAO, YY ZHUANG |
Nephrology | 1998 |
|
In search of a biological pattern for human longevity: Impact of apo A-IV genetic polymorphisms on lipoproteins and the hyper-Lp(a) in centenarians
G Pepe, VD Perna, F Resta, M Lovecchio, G Chimienti, AM Colacicco, A Capurso |
Atherosclerosis | 1998 |
|
Fibrinogen deficiency reduces vascular accumulation of apolipoprotein(a) and development of atherosclerosis in apolipoprotein(a) transgenic mice
XJ Lou, NW Boonmark, FT Horrigan, JL Degen, RM Lawn |
Proceedings of the National Academy of Sciences | 1998 |
|
Hormone replacement therapy in postmenopausal women with specific risk factors for coronary artery disease
M der Mooren |
Maturitas | 1998 |
|
Despite Its Homology to Angiostatin Apolipoprotein(a) Does Not Affect Angiogenesis
XJ Lou, HH Kwan, SD Prionas, ZJ Yang, RM Lawn, LF Fajardo |
Experimental and Molecular Pathology | 1998 |
|
Did grandma give you heart disease? The new battle against coronary artery disease
HR Superko |
The American Journal of Cardiology | 1998 |
|
Atherothrombogenicity of lipoprotein(a): the debate
AM Scanu |
The American Journal of Cardiology | 1998 |
|
Genetics in childhood atherosclerosis
RA Hegele |
Progress in Pediatric Cardiology | 1998 |
|
Elevated plasma levels of soluble P-selectin in patients with acute myocardial infarction and unstable angina
D Xu, S Zhao, W Peng |
International Journal of Cardiology | 1998 |
|
Apolipoprotein(a) phenotypes as genetic markers of coronary atherosclerosis severity
C Gazzaruso, D Geroldi, A Garzaniti, C Falcone, P Fratino, G Finardi, P Buscaglia |
International Journal of Cardiology | 1998 |
|
Evaluation of the new automated ELISA Vidas® Lp(a) assay
S Mesli, S Demailly, FL Moigne, P Derache, E Jouzier |
Clinica Chimica Acta | 1998 |
|
Mechanized lipoprotein(a) assay as a marker for coronary artery disease illustrates the usefulness of high lipoprotein(a) levels
GA Hobbs, IV Kaplan, SS Levinson |
Clinica Chimica Acta | 1998 |
|
High Level of Lipoprotein (a) is a Strong Predictor for Progression of Coronary Artery Disease
Y Matsumoto, H Daida, Y Watanabe, S Sunayama, H Mokuno, H Yokoi, H Yamaguchi |
Journal of Atherosclerosis and Thrombosis | 1998 |
|
Oxidative stress in chronic renal failure
O Hasselwander, IS Young |
Free Radical Research | 1998 |
|
Apolipoprotein(a) Gene Enhancer Resides within a LINE Element
Z Yang, D Boffelli, N Boonmark, K Schwartz, R Lawn |
The Journal of biological chemistry | 1998 |
|
Apolipoprotein(a) Synthesis and Secretion from Hepatoma Cells Is Coupled to Triglyceride Synthesis and Secretion
F Nassir, DK Bonen, NO Davidson |
The Journal of biological chemistry | 1998 |
|
Alcohol Withdrawal–Induced Change in Lipoprotein(a): Association With the Growth Hormone/Insulin-like Growth Factor-I (IGF-I)/IGF-Binding Protein-1 (IGFBP-1) Axis
M Paassilta, K Kervinen, M Linnaluoto, YA Kesäniemi |
Arteriosclerosis, thrombosis, and vascular biology | 1998 |
|
Unstable Coronary Artery Syndromes Pathophysiology, Diagnosis and Treatment
RL Wilensky |
1998 | |
|
Demonstration of Covalent Binding of Lipoprotein(a) [Lp(a)] to Fibrin and Endothelial Cells
JN Liu, W Kung, PC Harpel, V Gurewich |
Biochemistry | 1998 |
|
Inhibition of N-linked glycosylation results in retention of intracellular apo[a] in hepatoma cells, although nonglycosylated and immature forms of apolipoprotein[a] are competent to associate with apolipoprotein B-100 in vitro
DK Bonen, F Nassir, AM Hausman, NO Davidson |
Journal of lipid research | 1998 |
|
Plasma lipoprotein(a) levels and expression of the apolipoprotein(a) gene are dependent on the nucleotide polymorphisms in its 5'-flanking region
K Suzuki, M Kuriyama, T Saito, A Ichinose |
Journal of Clinical Investigation | 1997 |
|
Modification of apolipoprotein(a) lysine binding site reduces atherosclerosis in transgenic mice
NW Boonmark, XJ Lou, ZJ Yang, K Schwartz, JL Zhang, EM Rubin, RM Lawn |
Journal of Clinical Investigation | 1997 |
|
Biogenesis of Lp(a) in transgenic mouse hepatocytes
AL White |
Clinical Genetics | 1997 |
|
Native and γ radiolysis-oxidized lipoprotein(a) increase the adhesiveness of rabbit aortic endothelium
J Beaudeux |
Atherosclerosis | 1997 |
|
Association of Lp(a) rather than integrally-bound apo(a) with triglyceride-rich lipoproteins of human subjects
C Marcoux |
Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism | 1997 |
|
von Willebrand factor and soluble E-selectin in the prediction of cardiovascular disease progression in hyperlipidaemia
A Blann |
Atherosclerosis | 1997 |
|
Von Willebrand factor and soluble E-selectin in hyperlipidaemia: Relationship to lipids and vascular disease
AD Blann, A Davis, JP Miller, CN McCollum |
American Journal of Hematology | 1997 |
|
LDL Apheresis in Clinical Practice: Long-Term Treatment of Severe Hyperlipidemia
R Bambauer, R Schiel, R Latza, J Klinkmann, JM Schneidewind |
Therapeutic Apheresis and Dialysis | 1997 |
|
Quantitation of plasminogen epitopes of serum lipoprotein(a) by sandwich enzyme linked immunosorbent assay
JJ Wang, YY Zhaung, XD Yao |
Clinica Chimica Acta | 1997 |
|
The lysine-binding function of Lp(a)
NW Boonmark, RM Lawn |
Clinical Genetics | 1997 |
|
The genetic basis of atherosclerosis
RA Hegele |
International Journal of Clinical & Laboratory Research | 1997 |
|
Convergent evolution of apolipoprotein(a) in primates and hedgehog
RM Lawn, K Schwartz, L Patthy |
Proceedings of the National Academy of Sciences | 1997 |
|
Lipoprotein(a) Selectively Impairs Receptor-Mediated Endothelial Vasodilator Function of the Human Coronary Circulation
VS MD, MH MD, JM MD, AB MD, AM MD |
Journal of the American College of Cardiology | 1997 |
|
Lipoprotein lipase—enhanced binding of lipoprotein(a) [Lp(a)] to heparan sulfate is improved by apolipoprotein E (apoE) saturation: Secretion-capture process of ApoE is a possible route for the catabolism of Lp(a)
HH van Barlingen, HA Kleinveld, DW Erkelens, TW de Bruin |
Metabolism | 1997 |
|
Lipoprotein (a) distribution in a Nigerian population
RW Evans, CH Bunker, FA Ukoli, LH Kuller |
Ethnicity and Health | 1997 |
|
Small genetic effects in complex diseases: A review of regulatory sequence variants in dyslipoproteinemia and atherosclerosis
RA Hegele |
Clinical Biochemistry | 1997 |
|
Pentaerythritol tetranicotinate (niceritrol) decreases plasma lipoprotein(a) levels
K Tanaka, K Hayashi, T Shingu, Y Kuga, Y Okura, Y Yasunobu, H Ohtani, S Nomura, H Kurushima, M Saeki, M Kambe, G Kajiyama |
Metabolism | 1997 |
|
Influence of Allelic Variation on Apolipoprotein(a) Folding in the Endoplasmic Reticulum
AL White, B Guerra, RE Lanford |
The Journal of biological chemistry | 1997 |
|
Apolipoprotein E polymorphism has no independent effect on plasma levels of lipoprotein(a)
MM Ritter, J Gewitsch, WO Richter, HC Geiss, MW Wildner, P Schwandt |
Atherosclerosis | 1997 |
|
Ten-year follow-up results from the Goettingen Risk, Incidence and Prevalence Study (GRIPS). I. Risk factors for myocardial infarction in a cohort of 5790 men
P Cremer, D Nagel, H Mann, B Labrot, R Müller-Berninger, H Elster, D Seidel |
Atherosclerosis | 1997 |
|
Transgenic Mice Expressing Human ApoB95 and ApoB97: EVIDENCE THAT SEQUENCES WITHIN THE CARBOXYL-TERMINAL PORTION OF HUMAN apoB100 ARE IMPORTANT FOR THE ASSEMBLY OF LIPOPROTEIN(a)
SP McCormick, JK Ng, CM Cham, S Taylor, SM Marcovina, JP Segrest, RE Hammer, SG Young |
The Journal of biological chemistry | 1997 |
|
Platelet Integrin α IIb β3 (GPIIb-IIIa) Is Not Implicated in the Binding of LDL to Intact Resting Platelets
J Pedreño, R Fernández, C Cullaré, A Barceló, MA Elorza, C de Castellarnau |
Arteriosclerosis, thrombosis, and vascular biology | 1997 |
|
In Vivo Transfer of Lipoprotein(a) Into Human Atherosclerotic Carotid Arterial Intima
LB Nielsen, ML Grønholdt, TV Schroeder, S Stender, BG Nordestgaard |
Arteriosclerosis, thrombosis, and vascular biology | 1997 |
|
Hemostatic variables and ischemic cardiovascular disease: Do we need a concerted effort for more profitable future clinical investigations?
GD Minno, FP Mancini, M Margaglione |
Cardiovascular Drugs and Therapy | 1997 |
|
Homocysteine Metabolism: From Basic Science to Clinical Medicine
I Graham, H Refsum, IH Rosenberg, PM Ueland, JM Shuman |
1997 | |
|
LDL-mediated interaction of Lp[a] with HepG2 cells: a novel fluorescence microscopy approach
G Hofer, E Steyrer, GM Kostner, A Hermetter |
Journal of lipid research | 1997 |
|
Learning about the structure and biology of human lipoprotein [a] through dissection by enzymes of the elastase family: facts and speculations
AM Scanu, C Edelstein |
Journal of lipid research | 1997 |
|
Lipoprotein[a] is not present in the plasma of patients with some peroxisomal disorders
YY van der Hoek, RJ Wanders, AE van den Ende, HG Kraft, BR Gabel, JJ Kastelein, ML Koschinsky |
Journal of lipid research | 1997 |
|
Evidence that the fibrinogen binding domain of Apo(a) is outside the lysine binding site of kringle IV-10: a study involving naturally occurring lysine binding defective lipoprotein(a) phenotypes
O Klezovitch, C Edelstein, AM Scanu |
Journal of Clinical Investigation | 1996 |
|
Lipoprotein(a) in Cirrhosis. A New Index of Liver Functions?
M Malaguarnera, I Giugno, BA Trovato, MP Panebianco, N Restuccia, P Ruello |
Current Medical Research and Opinion | 1996 |
|
HYPERTENSION IN DIABETES MELLITUS
C Arauz-Pacheco, P Raskin |
Endocrinology & Metabolism Clinics of North America | 1996 |
|
Serum lipoprotein (a) in type 1 diabetic children and adolescents: Relationships with HbA1c and subclinical complications
D Willems, D Dufrasne, H Dorchy |
European Journal of Pediatrics | 1996 |
|
Effect of sample storage on quantitation of lipoprotein (a) by an enzyme-linked immunosorbent assay
RW Evans, SS Sankey, BA Hauth, K Sutton-Tyrrell, MI Kambon, LH Kuller |
Lipids | 1996 |
|
Plasma lipoprotein(a) distribution in the Framingham Offspring Study as determined with a commercially available immunoturbidimetric assay
JH Contois, CJ Lammi-Keefe, S Vogel, JR McNamara, PW Wilson, T Massov, EJ Schaefer |
Clinica Chimica Acta | 1996 |
|
PAF-acetylhydrolase activity on Lp(a) before and during Cu2+-induced oxidative modification in vitro
SA Karabina, MC Elisaf, J Goudevenos, KC Siamopoulos, D Sideris, AD Tselepis |
Atherosclerosis | 1996 |
|
Formaldehyde produced endogenously via deamination of methylamine. A potential risk factor for initiation of endothelial injury
PH Yu, DM Zuo |
Atherosclerosis | 1996 |
|
Lipoprotein(a) induces cell growth in rat peritoneal macrophages through inhibition of transforming growth factor-β activation
Y Sato, S Kobori, M Sakai, T Yano, T Higashi, T Matsumura, W Morikawa, T Terano, A Miyazaki, S Horiuchi, M Shichiri |
Atherosclerosis | 1996 |
|
Lipoprotein(a) is an independent risk factor for multiple cerebral infarctions
T Hiraga, M Shimada, M Okubo, K Nakanishi, T Kobayashi, T Murase |
Atherosclerosis | 1996 |
|
Lipoprotein (a) levels in alcohol drinking and alcohol non-drinking coronary artery disease patients
S Vasisht, DP Agarwal, HS Wasir, LM Srivastava |
Indian Journal of Clinical Biochemistry | 1996 |
|
Apolipoprotein(a) size and pentanucleotide repeat polymorphisms are associated with the degree of atherosclerosis in coronary heart disease
H Amemiya, T Arinami, S Kikuchi, K Yamakawa-Kobayashi, L Li, H Fujiwara, M Hiroe, F Marumo, H Hamaguchi |
Atherosclerosis | 1996 |
|
Factors influencing plasma lipid profiles including lipoprotein (a) concentrations in renal transplant recipients
DC Wheeler, R Morgan, DM Thomas, M Seed, A Rees, RH Moore |
Transplant International | 1996 |
|
Oxidation of fluorescent glycero- and sphingophospholipids in human plasma lipoproteins: Alkenylacyl subclasses are preferred targets
G Hofer |
Clinical Biochemistry | 1996 |
|
Identification of cryptic peanut agglutinin-reactive sites in human lipoprotein(a)
L Lee |
Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism | 1996 |
|
How often has Lp(a) evolved?
RM Lawn |
Clinical Genetics | 1996 |
|
Lipoprotein (a), homocysteine, and hypercoagulable states in young men with premature peripheral atherosclerosis: A prospective, controlled analysis
RJ Valentine, HS Kaplan, R Green, DW Jacobsen, SI Myers, GP Clagett |
Journal of Vascular Surgery | 1996 |
|
Physical activity, lipids, apolipoproteins, and Lp(a) in the Northern Ireland Health and Activity Survey
DO MacAULEY, EV McCRUM, G Stott, AE Evans, E Duly, TR Trinick, K Sweeney, CA Boreham |
Medicine & Science in Sports & Exercise | 1996 |
|
Effects of Anticoagulants on Lipoprotein(a) Measurements with Four Commercial Assays
G Lippi, L Giampaolo, G Guidi |
Clinical Chemistry and Laboratory Medicine | 1996 |
|
Interrelationship of triglyceride-rich lipoproteins, serum lipoprotein(a) concentration and apolipoprotein(a) size
M SentÍ, J Pedro-Botet, J Rubiés-Prat, J Marrugat |
Scandinavian Journal of Clinical & Laboratory Investigation | 1996 |
|
Oxidized lipoprotein (a) induces cell adhesion molecule Mac-1 (CD 11b) and enhances adhesion of the monocytic cell line U937 to cultured endothelial cells
MS Ragab, P Selvaraj, DS Sgoutas |
Atherosclerosis | 1996 |
|
Lipoprotein(a) and peripheral atherosclerosis in older adults
K Sutton-Tyrrell, RW Evans, E Meilahn, HG Alcorn |
Atherosclerosis | 1996 |
|
Lipoprotein(a): searching for a function
PC Harpel, M Poon, X Zhang, MB Taubman |
Transactions of the American Clinical and Climatological Association | 1996 |
|
PLASMA Lp(a) AND t-PA-PAI-1 COMPLEX LEVELS IN CORONARY HEART DISEASE
S Süer, T Ulutin, H Sönmez, E Kökoǧlu, N Üçişik, Ç Bayram, G Sultuybek |
Thrombosis Research | 1996 |
|
Lipoprotein Changes in Relation to Body Mass Index in Native American Adolescents
PR Blackett, T Taylor, D Russell, M Lu, J Fesmire, ET Lee |
Pediatric Research | 1996 |
|
Racial Variation of Cord Plasma Lipoprotein(a) Levels in Relation to Coronary Risk Level: A Study in Three Ethnic Groups in Singapore
PS Low, CK Heng, N Saha, JS Tay |
Pediatric Research | 1996 |
|
Oxidation of lipoprotein(a) and low density lipoprotein containing density gradient ultracentrifugation fractions
HA Kleinveld, PF Duif, HL Pekelharing, HJ van Rijn |
Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism | 1996 |
|
Cholesterol and coronary heart disease
AM Tonkin |
The Asia Pacific Heart Journal | 1996 |
|
Lipoprotein(a)-apheresis in the secondary prevention of coronary heart disease
H Ullrich, K Lackner, G Schmitz |
Transfusion Science | 1996 |
|
Fibrinolytic status of the normal human fetus: association with undetectable levels of histidin-rich glycoprotein and lipoprotein(a)
P Reverdiau-Moalic, V Billaud, G Body, Y Lebranchu, P Bardos, Y Gruel |
Fibrinolysis | 1996 |
|
Beyond LDL cholesterol reduction
HR Superko |
Circulation | 1996 |
|
Coronary heart disease risk factors in older persons
MC Corti, JM Guralnik, C Bilato |
Aging clinical and experimental research | 1996 |
|
Thrombolysis with tissue plasminogen activator enhances serum lipoprotein(a) levels compared to streptokinase and conservative treatment in patients with acute myocardial infarction
M Paassilta, K Kervinen, KJ Peuhkurinen, YA Kesäniemi |
Fibrinolysis | 1996 |
|
Copper deficiency increases hepatic apolipoprotein B secretion and mRNA editing in rats
SK Reaves, RC Hoogeveen, YR Wang, JY Wu, KY Lei |
American journal of physiology. Cell physiology | 1996 |
|
The Number of Identical Kringle IV Repeats in Apolipoprotein(a) Affects Its Processing and Secretion by HepG2 Cells
C Brunner, EM Lobentanz, A Pethö-Schramm, A Ernst, C Kang, H Dieplinger, HJ Müller, G Utermann |
The Journal of biological chemistry | 1996 |
|
The Binding Activity of the Macrophage Lipoprotein(a)/Apolipoprotein(a) Receptor Is Induced by Cholesterol via a Post-translational Mechanism and Recognizes Distinct Kringle Domains on Apolipoprotein(a)
GA Keesler, BR Gabel, CM Devlin, ML Koschinsky, I Tabas |
The Journal of biological chemistry | 1996 |
|
Lipoproteins in heart disease
A Basile-Borgia, JH Abel |
Perfusion | 1996 |
|
Lp(a) Levels and Atherosclerotic Vascular Disease in a Sample of Patients With Familial Hypercholesterolemia Sharing the Same Gene Defect
R Carmena, S Lussier-Cacan, M Roy, A Minnich, A Lingenhel, F Kronenberg, J Davignon |
Arteriosclerosis, thrombosis, and vascular biology | 1996 |
|
Plasma Lipoprotein(a) Levels in Subjects Attending a Metabolic Ward: Discrimination Between Individuals With and Without a History of Ischemic Stroke
M Margaglione, G DiMinno, E Grandone, E Celentano, G Vecchione, G Cappucci, M Grilli, FP Mancini, A Postiglione, S Panico, M Mancini |
Arteriosclerosis, thrombosis, and vascular biology | 1996 |
|
Specific Accumulation of Lipoprotein(a) in Balloon-Injured Rabbit Aorta In Vivo
LB Nielsen, S Stender, K Kjeldsen, BG Nordestgaard |
Circulation research | 1996 |
|
Drugs Affecting Lipid Metabolism
AM Gotto, R Paoletti, LC Smith, AL Catapano, AS Jackson |
1996 | |
|
Thrombotic vascular risk factors in inflammatory bowel disease
M Hudson, A Chitolie, RA Hutton, MS Smith, RE Pounder, AJ Wakefield |
Gut | 1996 |
|
Analysis of Apolipoproteins
MF Laker, K Evans |
Annals of Clinical Biochemistry | 1996 |
|
Elevated Llpoprotein(A) and Fibrinogen Serum Levels Increase the Cardiovascular Risk in Continuous Ambulatory Peritoneal Dialysis Patients
W Bartens, M Nauck, P Schollmeyer, C Wanner |
Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis | 1996 |
|
Ligand-Induced Conformational Change of Lipoprotein(a)
GM Fless, J Furbee, ML Snyder, SC Meredith |
Biochemistry | 1996 |
|
Hepatic gene transfer of the catalytic subunit of the apolipoprotein B mRNA editing enzyme results in a reduction of plasma LDL levels in normal and watanabe heritable hyperlipidemic rabbits
J Greeve, VK Jona, NR Chowdhury, MS Horwitz, JR Chowdhury |
Journal of lipid research | 1996 |
|
Neomycin inhibits secretion of apolipoprotein[a] by increasing retention on the hepatocyte cell surface
RE Lanford, L Estlack, AL White |
Journal of lipid research | 1996 |
|
The low density lipoprotein receptor is not required for normal catabolism of Lp(a) in humans
DJ Rader, WA Mann, W Cain, HG Kraft, D Usher, LA Zech, JM Hoeg, J Davignon, P Lupien, M Grossman |
Journal of Clinical Investigation | 1995 |
|
A pentanucleotide repeat polymorphism in the 5' control region of the apolipoprotein(a) gene is associated with lipoprotein(a) plasma concentrations in Caucasians
M Trommsdorff, S Köchl, A Lingenhel, F Kronenberg, R Delport, H Vermaak, L Lemming, IC Klausen, O Faergeman, G Utermann |
Journal of Clinical Investigation | 1995 |
|
Segregation analysis of plasma lipoprotein(a) levels in pedigrees with molecularly defined familial hypercholesterolemia
Y Friedlander, E Leitersdorf |
Genetic Epidemiology | 1995 |
|
The effect of reduction of lipoprotein (a) on cellular cholesterol synthesis in non-diabetic and Type 2 diabetic subjects
S Gilligan |
Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism | 1995 |
|
Effect of hypertriglyceridaemia on lipoprotein (a) serum concentrations
T Walek, AV Eckardstein, H Schulte, G Assmann |
European Journal of Clinical Investigation | 1995 |
|
Lipoprotein (a) in patients with hyperlipidaemia
W Bartens, DJ Rader, G Talley, HB Brewer |
European Journal of Clinical Investigation | 1995 |
|
Kringle-dependent structural and functional polymorphism of apolipoprotein (a)
A Scanu |
Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism | 1995 |
|
Red blood cell vitamin E concentrations in fetuses are related to but lower than those in mothers during gestation
O Cachia, CL Léger, P Boulot, MH Vernet, F Michel, AC Paulet, B Descomps |
American Journal of Obstetrics and Gynecology | 1995 |
|
Antifibrinolytic activity of apolipoprotein(a) in vivo: Human apolipoprotein(a) transgenic mice are resistant to tissue plasminogen activator-mediated thrombolysis
TM Palabrica, AC Liu, MJ Aronovitz, B Furie, RM Lawn, BC Furie |
Nature Medicine | 1995 |
|
Time-Resolved Immunofluorometric Assay for the Quantification of Lipoprotein(a) in Serum
U Missler, T Walek, E Stange |
Clinical Chemistry and Laboratory Medicine | 1995 |
|
Plasma Lipoprotein(a) and Its Relationship with Disease Activity in Patients withBehçet’sDisease
A Örem, O Değer, G Çimşit, SC Karahan, N Akyol, S Yldirimiş |
Clinical Chemistry and Laboratory Medicine | 1995 |
|
Lipoprotein (a) and apolipoprotein A-1 and B in schoolchildren whose grandparents had coronary and cerebrovascular events: A preliminary study of 12-13 year old Japanese children
T Okada, Y Sato, T Yamazaki, F Iwata, M Hara, H Kim, K Karasawa, M Ayusawa, T Fuchigami, K Harada, M Okuni, S Ryo |
Pediatrics International | 1995 |
|
The response-to-retention hypothesis of early atherogenesis
KJ Williams, I Tabas |
Arteriosclerosis, thrombosis, and vascular biology | 1995 |
|
Genetic variation in lipoprotein (a) levels in families enriched for coronary artery disease is determined almost entirely by the apolipoprotein (a) gene locus
CA DeMeester, X Bu, RJ Gray, AJ Lusis, JI Rotter |
The American Journal of Human Genetics | 1995 |
|
Diabète sucré et athérosclérose. Physiopathologie de la macroangiopathie diabétique
M Leutenegger, E Bertin |
La Revue de Médecine Interne | 1995 |
|
Comparison of effects of N-3 to N-6 fatty acids on serum level of lipoprotein(a) in patients with coronary artery disease
W Herrmann, J Biermann, GM Kostner |
The American Journal of Cardiology | 1995 |
|
Effects of fluvastatin on lipid profile andapolipoproteins in Chinese patients with hypercholesterolemia
B Tomlinson, TW Mak, JY Tsui, J Woo, CC Shek, JA Critchley, JR Masarei |
The American Journal of Cardiology | 1995 |
|
Immunopharmacology of Free Radical Species
C Rice-Evans |
Immunopharmacology of Free Radical Species | 1995 |
|
Identification of mutations in human apolipoprotein(a) kringle 4–37 from the study of the DNA of peripheral blood lymphocytes: Relevance to the role of lipoprotein(a) in atherothrombosis
AM Scanu |
The American Journal of Cardiology | 1995 |
|
Selected Aspects of ACE Inhibitor Therapy for Patients with Renal Disease: Impact on Proteinuria, Lipids and Potassium
T Keilani, W Schlueter, D Batlle |
The Journal of Clinical Pharmacology | 1995 |
|
Cellular Binding and Degradation of Lipoprotein (a)
GM Fless |
Journal of Atherosclerosis and Thrombosis | 1995 |
|
Effect of l-thyroxine therapy on lipoprotein fractions in overt and subclinical hypothyroidism, with special reference to lipoprotein(a)
R Arem, DA Escalante, N Arem, JD Morrisett, W Patsch |
Metabolism | 1995 |
|
Lipoprotein (a) in the Regulation of Fibrinolysis
JM Edelberg, SV Pizzo |
Journal of Atherosclerosis and Thrombosis | 1995 |
|
Effect of L-carnitine on elevated lipoprotein(a) levels
A Capurso, F Resta, AM Colacicco, E Vespertino, V Solfrizzi |
Current Therapeutic Research | 1995 |
|
Acute ischemic syndromes
RM Califf |
Medical Clinics of North America | 1995 |
|
Antioxidants and Cardiovascular Disease
KR Bruckdorfer |
1995 | |
|
Cyclical variation of plasma lipids, apolipoproteins, and lipoprotein(a) during menstrual cycle of normal women
G Tonolo, M Ciccarese, P Brizzi, S Milia, S Dessole, L Puddu, G Secchi, M Maioli |
American journal of physiology. Endocrinology and metabolism | 1995 |
|
A Comparison of Structure and Thermal Behavior in Human Plasma Lipoprotein(a) and Low-Density Lipoprotein. Calorimetry and Small-Angle X-ray Scattering
R Prassl, B Schuster, PM Abuja, M Zechner, GM Kostner, P Laggner |
Biochemistry | 1995 |
|
Loss of a Splice Donor Site at a ‘Skipped Exon’ in a Gene Homologous to Apolipoprotein(a) Leads to an mRNA Encoding a Protein Consisting of a Single Kringle Domain
CD Byrne, K Schwartz, RM Lawn |
Arteriosclerosis, thrombosis, and vascular biology | 1995 |
|
Effect of Glycation on the Properties of Lipoprotein(a)
K Makino, JW Furbee, AM Scanu, GM Fless |
Arteriosclerosis, thrombosis, and vascular biology | 1995 |
|
Multiple Risk Factors in Cardiovascular Disease
AM Gotto, C Lenfant, AL Catapano, R Paoletti |
1995 | |
|
Genetic Models of Human Vascular Disease
VJ Dzau, GH Gibbons, BK Kobilka, RM Lawn, RE Pratt |
Circulation | 1995 |
|
Transfer of Lipoprotein(a) and LDL Into Aortic Intima in Normal and in Cholesterol-Fed Rabbits
LB Nielsen, BG Nordestgaard, S Stender, A Niendorf, K Kjeldsen |
Arteriosclerosis, thrombosis, and vascular biology | 1995 |
|
Hormonal Regulation of Serum Lipoprotein(a) Levels: Contrasting Effects of Growth Hormone and Insulin-Like Growth Factor–I
H Olivecrona, AG Johansson, E Lindh, S Ljunghall, L Berglund, B Angelin |
Arteriosclerosis, thrombosis, and vascular biology | 1995 |
|
Dose-Response Relationships of Serum Lipid Measurements With the Extent of Coronary Stenosis: Strong, Independent, and Comprehensive
I Bolibar, SG Thompson, A von Eckardstein, M Sandkamp, G Assmann |
Arteriosclerosis, thrombosis, and vascular biology | 1995 |
|
Molekularbiologische Grundlagen der Gastroenterologie
HG Beger, MP Manns, H Greten |
1995 | |
|
Lipoprotein (a) and vascular disease in diabetic patients
RW James, M Boemi, C Sirolla, L Amadio, P Fumelli, D Pometta |
Diabetologia | 1995 |
|
Gemfibrozil and mediterranean diet for patients with high plasma levels of lipoprotein [Lp(a)] and cholesterol?Pilot study
G Simoni, A Gianotti, A Ardia, A Baiardi, D Civalleri |
Cardiovascular Drugs and Therapy | 1995 |
|
Cardiovascular Disease 2
LL Gallo |
1995 | |
|
Omega-3 Fatty Acids and Health
JA Nettleton |
1995 | |
|
Oxidativer Stress in der Kinderheilkunde
H Böhles |
1995 | |
|
Ten allelic apolipoprotein[a] 5' flanking fragments exhibit comparable promoter activities in HepG2 cells
S Bopp, S Köchl, F Acquati, P Magnaghi, A Pethö-Schramm, HG Kraft, G Utermann, HJ Müller, R Taramelli |
Journal of lipid research | 1995 |
|
Variation in lipoprotein(a) concentration associated with different apolipoprotein(a) alleles
YF Perombelon, AK Soutar, BL Knight |
Journal of Clinical Investigation | 1994 |
|
Comparative analysis of the apo(a) gene, apo(a) glycoprotein, and plasma concentrations of Lp(a) in three ethnic groups. Evidence for no common "null" allele at the apo(a) locus
A Gaw, E Boerwinkle, JC Cohen, HH Hobbs |
Journal of Clinical Investigation | 1994 |
|
The inverse association of plasma lipoprotein(a) concentrations with apolipoprotein(a) isoform size is not due to differences in Lp(a) catabolism but to differences in production rate
DJ Rader, W Cain, K Ikewaki, G Talley, LA Zech, D Usher, HB Brewer |
Journal of Clinical Investigation | 1994 |
|
The role of lecithin: cholesterol acyltransferase for lipoprotein (a) assembly. Structural integrity of low density lipoproteins is a prerequisite for Lp(a) formation in human plasma
E Steyrer, S Durovic, S Frank, W Giessauf, A Burger, H Dieplinger, R Zechner, GM Kostner |
Journal of Clinical Investigation | 1994 |
|
Effects of dietary fat saturation on plasma lipoprotein(a) and hepatic apolipoprotein(a) mRNA concentrations in cynomolgus monkeys
ME Brousseau, JM Ordovas, RJ Nicolosi, EJ Schaefer |
Atherosclerosis | 1994 |
|
Studies on the structure and function of the apolipoprotein(a) gene
CD Byrne, RM Lawn |
Clinical Genetics | 1994 |
|
Lipoprotein(a) in Type 1 Diabetic Patients with Renal Disease
PH Groop, GC Viberti, TG Elliott, R Friedman, A Mackie, C Ehnholm, M Jauhiainen, MR Taskinen |
Diabetic Medicine | 1994 |
|
Apolipoprotein (a) phenotypes and lipoprotein (a) concentrations in patients with type III hyperlipoproteinaemia
G Feussner, V Feussner, R Ziegler |
Journal of Internal Medicine | 1994 |
|
Fluorescence labeling and interaction of atherogenic lipoproteins with cultured cells
G Hofer, R Gorges, GM Kostner, F Paltauf, A Hermetter |
Journal of Fluorescence | 1994 |
|
Decreased plasma levels of lipoprotein(a) in patients with hypertriglyceridemia
W Bartens, DJ Rader, G Talley, HB Brewer |
Atherosclerosis | 1994 |
|
Lipoprotein (a): implication in atherothrombosis
MJ Chapman, T Huby, F Nigon, J Thillet |
Atherosclerosis | 1994 |
|
Lysine-binding species of lipoprotein(a) in coronary artery disease
I Karmansky, H Shnaider, A Palant, N Gruener |
European Journal of Clinical Investigation | 1994 |
|
Hypofibrinolysis: A common, major cause of osteonecrosis
CJ Glueck, R Freiberg, HJ Glueck, C Henderson, M Welch, T Tracy, D Stroop, T Hamer, F Sosa, M Levy |
American Journal of Hematology | 1994 |
|
Estrogen Therapy for the Lipid Abnormalities of Women on Dialysis
W Owen, EG Boston |
Seminars in Dialysis | 1994 |
|
Apolipoprotein(a): structural and functional consequences of mutations in kringle type 10 (or kringle 4-37)
AM Scanu, C Edelstein |
Clinical Genetics | 1994 |
|
The role of liver in glucose homeostasis in type 2 diabetes: The modernity of claude bernard's studies
D Lippi, D Caleri, A Bucalossi, CM Rotella |
Diabetes / Metabolism Reviews | 1994 |
|
Structural requirements of apo-a for the lipoprotein-a assembly
S Frank, S Durovic, GM Kostner |
Biochemical Journal | 1994 |
|
Expression of human apolipoprotein B and assembly of lipoprotein(a) in transgenic mice
MJ Callow, LJ Stoltzfus, RM Lawn, EM Rubin |
Proceedings of the National Academy of Sciences | 1994 |
|
Lipoprotein(a) concentrations and phenotypes in controls and patients with hypercholesterolemia or hypertriglyceridemia
MM Ritter, HC Geiss, WO Richter, P Schwandt |
Metabolism | 1994 |
|
A rapid and simple method for measuring the susceptibility of low-density-lipoprotein and very-low-density-lipoprotein to copper-catalyzed oxidation
A Zhang, J Vertommen, LV Gaal, ID Leeuw |
Clinica Chimica Acta | 1994 |
|
Electron cryomicroscopy and digital image processing of lipoprotein(a)
J Sines, R Rothnagel, M Heel, JW Gaubatz, JD Morrisett, W Chiu |
Chemistry and Physics of Lipids | 1994 |
|
The relation of LDL receptor activity to lipoprotein(a) plasma concentration in patients without coronary artery disease
G Ghiselli, A Gaddi |
Chemistry and Physics of Lipids | 1994 |
|
The apolipoprotein(a) gene: characterization of 5′ flanking regions and expression in transgenic mice
RM Lawn |
Chemistry and Physics of Lipids | 1994 |
|
Post-prandial Lp(a): identification of a triglyceride-rich particle containing apo E
AM Scanu, D Pfaffinger, C Edelstein |
Chemistry and Physics of Lipids | 1994 |
|
Lipoprotein(a) as a risk factor for preclinical atherosclerotic disease in a biracial cohort: the Atherosclerosis Risk in Communities (ARIC) Study
PJ Schreiner |
Chemistry and Physics of Lipids | 1994 |
|
Lipoprotein (a) displays increased accumulation compared with low-density lipoprotein in the murine arterial wall
J Kreuzer, MB Lloyd, D Bok, GM Fless, AM Scanu, AJ Lusis, ME Haberland |
Chemistry and Physics of Lipids | 1994 |
|
Immunochemically detectable lipid-free apo(a) in plasma and in human atherosclerotic lesions
HF Hoff, J O'Neil, GB Smejkal, A Yashiro |
Chemistry and Physics of Lipids | 1994 |
|
Hormonal agents used in lowering lipoprotein(a)
MR Soma, M Meschia, F Bruschi, JD Morrisett, R Paoletti, R Fumagalli, PG Crosignani |
Chemistry and Physics of Lipids | 1994 |
|
Identification and quantification of apolipoproteins in addition to apo[a] and apo B-100 in human lipoprotein[a]
F Blanco-Vaca, JW Gaubatz, N Bren, BA Kottke, JD Morrisett, J Guevara |
Chemistry and Physics of Lipids | 1994 |
|
Lipoprotein (a) regulates plasmin generation and inihibition
J Edelberg, SV Pizzo |
Chemistry and Physics of Lipids | 1994 |
|
Effects of lipoprotein(a) on the binding of plasminogen to fibrin and its activation by fibrin-bound tissue-type plasminogen activator
E Anglés-Cano, L Hervio, D Rouy, C Fournier, JM Chapman, M Laplaud, ML Koschinsky |
Chemistry and Physics of Lipids | 1994 |
|
Intracellular processing of apo(a) in primary baboon hepatocytes
AL White, DL Rainwater, JE Hixson, LE Estlack, RE Lanford |
Chemistry and Physics of Lipids | 1994 |
|
Oxidative modification of Lp(a) causes changes in the structure and biological properties of apo(a)
M Naruszewicze, LM Giroux, J Davignon |
Chemistry and Physics of Lipids | 1994 |
|
Structure and Possible biological roles of Lp(a)
I Karmansky, N Gruener |
Clinical Biochemistry | 1994 |
|
14 Lipoproteins and the haemostatic system in atherothrombotic disorders
GJ Miller |
Baillière's Clinical Haematology | 1994 |
|
Regulation of cholesteryl ester transfer protein (CETP) activity: review of in vitro and in vivo studies
L Lagrost |
Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism | 1994 |
|
Close relation between lipoprotein (a) levels and atherothrombotic disease in Japanese subjects >75 years of age
K Kario, T Matsuo, M Imiya, K Kayaba, T Kuroda, N Nago, H Matsuo, K Shimada |
The American Journal of Cardiology | 1994 |
|
Update on the metabolic effects of steroidal contraceptives and their relationship to cardiovascular disease risk
IF Godsland, D Crook |
American Journal of Obstetrics and Gynecology | 1994 |
|
Induction of oxygen free radical generation in human monocytes by lipoprotein(a)
PR Hansen, A Kharazmi, M Jauhiainen, C Ehnholm |
European Journal of Clinical Investigation | 1994 |
|
A screening method for abnormally high lipoprotein(a) concentrations by agarose lipoprotein electrophoresis
E Campos, P Fiévet, E Cacès, JC Fruchart, C Fiévet |
Clinica Chimica Acta | 1994 |
|
LDL apheresis using the liposorber® LA-15 system in coronary and peripheral vascular disease associated with severe hypercholesterolemia
T Agishi, W Wood, B Gordon |
Current Therapeutic Research | 1994 |
|
Lipoprotein Lp(a) as predictor of myocardial infarction in comparison to fibrinogen, LDL cholesterol and other risk factors: results from the prospective Göttingen Risk Incidence and Prevalence Study (GRIPS)
P Cremer, D Nagel, B Labrot, H Mann, R Muche, H Elster, D Seidel |
European Journal of Clinical Investigation | 1994 |
|
Lipoprotein(a) as a correlate of stroke and transient ischemic attack prevalence in a biracial cohort: The ARIC study
PJ Schreiner, LE Chambless, SA Brown, RL Watson, J Toole, G Heiss |
Annals of Epidemiology | 1994 |
|
Lipid Abnormalities in the Nephrotic Syndrome: Causes, Consequences, and Treatment
DC Wheeler, DB Bernard |
American Journal of Kidney Diseases | 1994 |
|
Genetic Architecture of the Atherogenic Lipoprotein(a)
G UTERMANN, C HAIBACH, M TROMMSDORFF, S KÖCHL, A LINGENHEL, A ABE, HG Kraft |
Annals of the New York Academy of Sciences | 1994 |
|
High-Level Expression of Various Apolipoprotein (a) Isoforms by "Transferrinfection": The Role of Kringle IV Sequences in the Extracellular Association with Low-Density Lipoprotein
S Frank, K Krasznai, S Durovic, EM Lobentanz, H Dieplinger, E Wagner, K Zatloukal, M Cotten, G Utermann |
Biochemistry | 1994 |
|
Lipoprotein(A): Physiologic Function, Association with Atherosclerosis, and Effects of Lipid-Lowering Drug Therapy
DF Thompson, MA Raebel, SA Spinler, MJ Cziraky |
The Annals of pharmacotherapy | 1994 |
|
Lipoprotein(a) and atherogenesis
AC Liu, RM Lawn |
Trends in Cardiovascular Medicine | 1994 |
|
RNA editing of the apolipoprotein B gene
NO Davidson |
Trends in Cardiovascular Medicine | 1994 |
|
A single point mutation (Trp72 → Arg) in human apo(a) kringle 4-37 associated with a lysine binding defect in Lp(a)
AM Scanu, D Pfaffinger, JC Lee, J Hinman |
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease | 1994 |
|
Macrophage foam cell lipoprotein(a)/apoprotein(a) receptor. Cell-surface localization, dependence of induction on new protein synthesis, and ligand specificity
GA Keesler, Y Li, PJ Skiba, GM Fless, I Tabas |
Arteriosclerosis Thrombosis and Vascular Biology | 1994 |
|
Identification of glycoprotein IIb as the lipoprotein(a)-binding protein on platelets. Lipoprotein(a) binding is independent of an arginyl-glycyl-aspartate tripeptide located in apolipoprotein(a)
E Malle, A Ibovnik, A Stienmetz, GM Kostner, W Sattler |
Arteriosclerosis Thrombosis and Vascular Biology | 1994 |
|
Lack of association between sex hormones and Lp(a) concentrations in American and Finnish men
SM Haffner, L Mykkanen, KK Gruber, DL Rainwater, M Laakso |
Arteriosclerosis Thrombosis and Vascular Biology | 1994 |
|
Association of apolipoprotein(a) phenotypes in children with family history of premature coronary artery disease
S Islam, B Gutin, C Smith, F Treiber, MI Kamboh |
Arteriosclerosis Thrombosis and Vascular Biology | 1994 |
|
The human apolipoprotein(a)/plasminogen gene cluster contains a novel homologue transcribed in liver
CD Byrne, K Schwartz, K Meer, JF Cheng, RM Lawn |
Arteriosclerosis Thrombosis and Vascular Biology | 1994 |
|
Binding of recombinant apolipoprotein(a) to extracellular matrix proteins
YY van der Hoek, W Sangrar, GP Côté, JJ Kastelein, ML Koschinsky |
Arteriosclerosis Thrombosis and Vascular Biology | 1994 |
|
Plasma Lp(a) levels correlate with number, severity, and length-extension of coronary lesions in male patients undergoing coronary arteriography for clinically suspected coronary atherosclerosis
T Budde, C Fechtrup, E Bösenberg, C Vielhauer, A Enbergs, H Schulte, G Assmann, G Breithardt |
Arteriosclerosis Thrombosis and Vascular Biology | 1994 |
|
Association of elevated lipoprotein(a) levels and coronary heart disease in NIDDM patients. Relationship with apolipoprotein(a) phenotypes
J Ruiz, J Thillet, T Huby, RW James, D Erlich, P Flandre, P Froguel, J Chapman, P Passa |
Diabetologia | 1994 |
|
Expression of human apolipoprotein B90 in transgenic mice. Demonstration that apolipoprotein B90 lacks the structural requirements to form lipoprotein
SP McCormick, MF Linton, HH Hobbs, S Taylor, LK Curtiss, SG Young |
The Journal of biological chemistry | 1994 |
|
Apolipoprotein B-38.9 does not associate with apo[a] and forms two distinct HDL density particle populations that are larger than HDL
WA Groenewegen, MR Averna, J Pulai, ES Krul, G Schonfeld |
Journal of lipid research | 1994 |
|
Molecular basis for “null” lipoprotein(a) phenotypes and the influence of apolipoprotein(a) size on plasma lipoprotein(a) level in the baboon
AL White, JE Hixson, DL Rainwater, RE Lanford |
The Journal of biological chemistry | 1994 |
|
Cell surface assembly of lipoprotein(a) in primary cultures of baboon hepatocytes
AL White, RE Lanford |
The Journal of biological chemistry | 1994 |
|
Decreased binding of apolipoprotein (a) to familial defective apolipoprotein B-100 (Arg3500–>Gln). A study of the assembly of recombinant apolipoprotein (a) with mutant low density lipoproteins
S Durovic, W Mrz, S Frank, H Scharnagl, MW Baumstark, R Zechner, GM Kostner |
The Journal of biological chemistry | 1994 |
|
Apolipoprotein[a] is not associated with apolipoprotein B in human liver
J Wilkinson, LH Munro, JA Higgins |
Journal of lipid research | 1994 |
|
Interferon-gamma down-regulates the lipoprotein(a)/apoprotein(a) receptor activity on macrophage foam cells. Evidence for disruption of ligand-induced receptor recycling by interferon-gamma
PJ Skiba, GA Keesler, I Tabas |
The Journal of biological chemistry | 1994 |
|
Lipoprotein(a) : new insights into an atherogenic lipoprotein
W Bartens, C Wanner |
The Clinical Investigator | 1994 |
|
Transdermal Estradiol/Norethisterone: A Review of its Pharmacological Properties and Clinical Use in Postmenopausal Women
LR Wiseman, D McTavish |
Drugs & Aging | 1994 |
|
Elevated endothelin levels in patients with hyperlipoproteinemia
T Haak, W Mrz, E Jungmann, S Hausser, R Siekmeier, W Gross, KH Usadel |
The Clinical Investigator | 1994 |
|
Rhesus monkey lipoprotein(a) binds to lysine Sepharose and U937 monocytoid cells less efficiently than human lipoprotein(a). Evidence for the dominant role of kringle 4(37)
AM Scanu, LA Miles, GM Fless, D Pfaffinger, J Eisenbart, E Jackson, JL Hoover-Plow, T Brunck, EF Plow |
Journal of Clinical Investigation | 1993 |
|
Variation in lipoprotein(a) concentrations among individuals with the same apolipoprotein (a) isoform is determined by the rate of lipoprotein(a) production
DJ Rader, W Cain, LA Zech, D Usher, HB Brewer |
Journal of Clinical Investigation | 1993 |
|
Sequence polymorphisms in the apolipoprotein (a) gene. Evidence for dissociation between apolipoprotein(a) size and plasma lipoprotein(a) levels
JC Cohen, G Chiesa, HH Hobbs |
Journal of Clinical Investigation | 1993 |
|
Transgenic mice expressing high plasma concentrations of human apolipoprotein B100 and lipoprotein(a)
MF Linton, RV Farese, G Chiesa, DS Grass, P Chin, RE Hammer, HH Hobbs, SG Young |
Journal of Clinical Investigation | 1993 |
|
Effects of pravastatin on apolipoprotein-specific high density lipoprotein subpopulations and low density lipoprotein subclass phenotypes in patients with primary hypercholesterolemia
MC Cheung, MA Austin, P Moulin, AC Wolf, D Cryer, RH Knopp |
Atherosclerosis | 1993 |
|
Automated latex nephelometric immunoassay for the measurement of serum lipoprotein (a)
L Borque, A Rus, J Cura, C Maside, J Escanero |
Journal of Clinical Laboratory Analysis | 1993 |
|
Relation of lipoprotein(a) to coronary heart disease and duplexsonographic findings of the carotid arteries in heterozygous familial hypercholesterolemia
F Tatò, C Keller, H Schuster, F Spengel, G Wolfram, N Zöllner |
Atherosclerosis | 1993 |
|
Plasma triglycerides and lipoprotein(a): inverse relationship in a hyperlipidemic Italian population
JP Werba, O Safa, G Gianfranceschi, S Michelagnoli, CR Sirtori, G Franceschini |
Atherosclerosis | 1993 |
|
Lipoprotein(a) plasma concentrations associated with lipolytic activities in eight kindreds with familial combined hyperlipidemia and normolipidemic subjects
MC Cabezas, TW de Bruin, MV Trip, LA Kock, H Jansen, DW Erkelens |
Metabolism | 1993 |
|
Homocysteine metabolism and the oxidative modification of proteins and lipids☆
AJ Olszewski, KS McCully |
Free radical biology & medicine | 1993 |
|
Plasma lipoprotein(a) levels in patients having chronic renal failure with and without diabetes mellitus
K Makino, MA Josephson, SK Fellner, AM Scanu |
Atherosclerosis | 1993 |
|
Lp(a) levels and antiestrogen antibodies in women with and without thrombosis in the course of oral contraception
B Delplanque, V Beaumont, N Lemort, JL Beaumont |
Atherosclerosis | 1993 |
|
Immunoquantification of lipoprotein(a): Comparison of nephelometry with electroimmunodiffusion
A Tiran, B Tiran, S Hojas, GM Kostner, MM Wilders-Truschnig |
Journal of Clinical Laboratory Analysis | 1993 |
|
Postmenopausal Hormone Replacement Therapy with Tibolone Decreases Serum Lipoprotein(a)
W Haenggi, W Riesen, MH Birkhaeuser |
Clinical Chemistry and Laboratory Medicine | 1993 |
|
Serum lipoprotein(a) levels in elderly black and white men in the Charleston Heart Study
RG Knapp, PJ Schreiner, SE Sutherland, JE Keil, GE Gilbert, RL Klein, C Hames, HA Tyroler |
Clinical Genetics | 1993 |
|
Granulocyte and granulocyte-macrophage colony-stimulating factors
A Laplanche, WP Steward, PR Hansen, D Hovgaard |
The Lancet | 1993 |
|
5' control regions of the apolipoprotein(a) gene and members of the related plasminogen gene family
DP Wade, JG Clarke, GE Lindahl, AC Liu, BR Zysow, K Meer, K Schwartz, RM Lawn |
Proceedings of the National Academy of Sciences | 1993 |
|
Cys4057 of apolipoprotein(a) is essential for lipoprotein(a) assembly
C Brunner, HG Kraft, G Utermann, HJ Müller |
Proceedings of the National Academy of Sciences | 1993 |
|
Lipoprotein(a) and its role in occlusive vascular disease
M Tennant, JK McGeachie |
Annals of the Royal College of Surgeons of England | 1993 |
|
Tamoxifen decreases the rate of proliferation of rat vascular smooth-muscle cells in culture by inducing production of transforming growth factor beta
DJ Grainger, PL Weissberg, JC Metcalfe |
Biochemical Journal | 1993 |
|
Lipoprotein(a) serum concentration in familial combined hyperlipidemia
M Fonda, PG da Col, RL Verde, C Battello, M Fisicaro, M Tonizzo, L Cattin |
Clinica Chimica Acta | 1993 |
|
Disturbances of lipid metabolism in children with chronic renal failure
U Querfeld |
Pediatric Nephrology | 1993 |
|
Characterization of apo(a) polymorphism by a modified immunoblotting technique in an italian population sample
D Geroldi, V Bellotti, P Buscaglia, G Bonetti, C Gazzaruso, A Caprioli, P Fratino |
Clinica Chimica Acta | 1993 |
|
Plasma predictors of ischemic complications of atherosclerosis: open issues
M Margaglione, E Grandone, GD Minno |
Biomedicine & Pharmacotherapy | 1993 |
|
Metabolic effects of converting enzyme inhibitors: Focus on the reduction of cholesterol and lipoprotein(a) by fosinopril
W Schlueter, T Keilani, DC Batlle |
The American Journal of Cardiology | 1993 |
|
Alteration of lipoprotein(a) concentration with glycemic control in non-insulin-dependent diabetic subjects without diabetic complications
H Nakata, K Horita, M Eto |
Metabolism | 1993 |
|
Immunonephelometric/turbidimetric apolipoprotein B assays for the clinical laboratory
SS Levinson, SG Wagner |
Clinica Chimica Acta | 1993 |
|
Structural basis for the presumptive atherothrombogenic action of lipoprotein(a)
AM Scanu |
Biochemical Pharmacology | 1993 |
|
Serum lipoprotein(a) levels differ in different phenotypes of primary hyperlipoproteinemia
T Hiraga, M Okubo, T Kobayashi, K Nakanishi, T Sugimoto, T Murase |
Metabolism | 1993 |
|
Inheritance conjointly contributing to fibrinolysis and hyperlipidemia
CJ Glueck, HI Glueck, T Tracy, J Speirs, D Stroop |
Metabolism | 1993 |
|
Lipoprotein Metabolism and Renal Failure
PO Attman, O Samuelsson, P Alaupovic |
American Journal of Kidney Diseases | 1993 |
|
Cardiovascular Disorders (Risk Assessment)
DW Jacobsen |
Analytical Chemistry | 1993 |
|
Physical properties of recombinant apolipoprotein(a) and its association with LDL to form an Lp(a)-like complex
ML Phillips, AV Lembertas, VN Schumaker, RM Lawn, SJ Shire, TF Zioncheck |
Biochemistry | 1993 |
|
Growth hormone treatment of growth hormone-deficient adults results in a marked increase in Lp(a) and HDL cholesterol concentrations
S Edén, O Wiklund, J Oscarsson, T Rosén, BA Bengtsson |
Arteriosclerosis Thrombosis and Vascular Biology | 1993 |
|
Interaction of Lp(a) and of apo(a) with liver cells
GM Kostner |
Arteriosclerosis Thrombosis and Vascular Biology | 1993 |
|
Glutamine/histidine polymorphism in apo A-IV affects plasma concentrations of lipoprotein(a) and fibrin split products in coronary heart disease patients
A von Eckardstein, J Heinrich, H Funke, H Schulte, R Schönfeld, E Köhler, A Steinmetz, G Assmann |
Arteriosclerosis Thrombosis and Vascular Biology | 1993 |
|
Effects of age, sex, and menopausal status on plasma lipoprotein(a) levels. The Framingham Offspring Study
JL Jenner, JM Ordovas, S Lamon-Fava, MM Schaefer, PW Wilson, WP Castelli, EJ Schaefer |
Circulation | 1993 |
|
Plasma lipoprotein and apolipoprotein levels in Taipei and Framingham
LC Lyu, MJ Shieh, JM Ordovas, AH Lichtenstein, PW Wilson, EJ Schaefer |
Arteriosclerosis Thrombosis and Vascular Biology | 1993 |
|
High serum lipoprotein(a) levels are an independent risk factor for cerebral infarction
S Shintani, S Kikuchi, H Hamaguchi, T Shiigai |
Stroke; a journal of cerebral circulation | 1993 |
|
Frequent occurrence of familial aggregations of high lipoprotein(a) levels associated with small apolipoprotein(a) isoforms
H Yanagi, A Nakagawa, S Kikuchi, T Tanaka, S Tsuchiya, H Hamaguchi |
Human Genetics | 1993 |
|
High degree of genetic polymorphism in apolipoprotein(a) associated with plasma lipoprotein(a) levels in Japanese and Chinese populations
S Kikuchi, A Nakagawa, K Kobayashi, L Li, H Yanagi, T Arinami, Y Kozu, R Miyazaki, S Tsuchiya, H Hamaguchi |
Human Genetics | 1993 |
|
Lipoprotein (a) as an independent risk factor for myocardial infarction in patients with common hypercholesterolaemia
GF Watts, EM Kearney, NA Taub, BM Slavin |
Journal of clinical pathology | 1993 |
|
Advances in Human Genetics 21
H Harris, K Hirschhorn |
1993 | |
|
Cellular Metabolism of the Arterial Wall and Central Nervous System
G Schettler, H Greten, AJ Habenicht |
1993 | |
|
Apolipoprotein B mRNA Editing: A Key Controlling Element Targeting Fats to Proper Tissue
NO Davidson |
Annals of Medicine | 1993 |
|
Proliferation of Human Smooth Muscle Cells Promoted by Lipoprotein(a)
DJ Grainger, HL Kirschenlohr, JC Metcalfe, PL Weissberg, DP Wade, RM Lawn |
Science | 1993 |
|
Familial hypobetalipoproteinemia
MF Linton, RV Farese, SG Young |
Journal of lipid research | 1993 |
|
Lipoprotein lipase and sphingomyelinase synergistically enhance the association of atherogenic lipoproteins with smooth muscle cells and extracellular matrix. A possible mechanism for low density lipoprotein and lipoprotein(a) retention and macrophage foam cell formation
I Tabas, Y Li, RW Brocia, SW Xu, TL Swenson, KJ Williams |
The Journal of biological chemistry | 1993 |
|
Cholesterol loading of macrophages leads to marked enhancement of native lipoprotein(a) and apoprotein(a) internalization and degradation
LA Bottalico, GA Keesler, GM Fless, I Tabas |
The Journal of biological chemistry | 1993 |
|
Identification of the cysteine residue in apolipoprotein(a) that mediates extracellular coupling with apolipoprotein B-100
ML Koschinsky, GP Côté, B Gabel, YY van der Hoek |
The Journal of biological chemistry | 1993 |
|
Partial characterization of lipoproteins containing apo[a] in human atherosclerotic lesions
HF Hoff, J O'Neil, A Yashiro |
Journal of lipid research | 1993 |
|
Relation of cardiovascular risk factors to atherosclerosis in type III hyperlipoproteinemia
G Feussner, A Wagner, R Ziegler |
Human Genetics | 1993 |
|
Clinical features of type III hyperlipoproteinemia: analysis of 64 patients
G Feussner, A Wagner, B Kohl, R Ziegler |
The Clinical Investigator | 1993 |
|
Apolipoprotein(a) phenotypes, Lp(a) concentration and plasma lipid levels in relation to coronary heart disease in a Chinese population: evidence for the role of the apo(a) gene in coronary heart disease
C Sandholzer, E Boerwinkle, N Saha, MC Tong, G Utermann |
Journal of Clinical Investigation | 1992 |
|
Hormonal regulation of serum Lp (a) levels. Opposite effects after estrogen treatment and orchidectomy in males with prostatic carcinoma
P Henriksson, B Angelin, L Berglund |
Journal of Clinical Investigation | 1992 |
|
Apolipoprotein(a) gene accounts for greater than 90% of the variation in plasma lipoprotein(a) concentrations
E Boerwinkle, CC Leffert, J Lin, C Lackner, G Chiesa, HH Hobbs |
Journal of Clinical Investigation | 1992 |
|
Distribution of apolipoprotein(a) in the plasma from patients with lipoprotein lipase deficiency and with type III hyperlipoproteinemia. No evidence for a triglyceride-rich precursor of lipoprotein(a)
C Sandholzer, G Feussner, J Brunzell, G Utermann |
Journal of Clinical Investigation | 1992 |
|
Genetic basis and pathophysiological implications of high plasma Lp(a) levels
AM Scanu |
Journal of Internal Medicine | 1992 |
|
Lipoprotein(a): a new independent risk factor for atherosclerosis
G Fulcher |
Australian and New Zealand Journal of Medicine | 1992 |
|
Effect of pravastatin and cholestyramine on triglyceride-rich lipoprotein particles and Lp(a) in patients with type II hypercholesterolemia
G Barbi, CN Corder, E Koren, W McConathy, SQ Ye, P Wilson |
Drug Development Research | 1992 |
|
Fibrin, Lipoprotein(a), Plasmin Interactions: A Model Linking Thrombosis and Atherogenesis
PC Harpel, W Borth |
Annals of the New York Academy of Sciences | 1992 |
|
The apolipoprotein(a) moiety of lipoprotein(a) interacts with the complement activation fragment iC3b but does not functionally affect C3 activation or degradation
PS Seifert, I Roth, TF Zioncheck |
Atherosclerosis | 1992 |
|
Lipoprotein(a) in women twins: heritability and relationship to apolipoprotein(a) phenotypes
MA Austin, C Sandholzer, JV Selby, B Newman, RM Krauss, G Utermann |
The American Journal of Human Genetics | 1992 |
|
Oxidative modification of lipoprotein(a) and the effect of β-carotene
M Naruszewicz, E Selinger, J Davignon |
Metabolism | 1992 |
|
A simple, sensitive technique for classification of apolipoprotein(a) isoforms by sodium dodecyl sulphate-polyacrylamide gel electrophoresis
M Farrer, FL Game, PC Adams, MF Laker, KG Alberti |
Clinica Chimica Acta | 1992 |
|
Plasma lipoprotein(a) concentration in familial hypercholesterolemic patients without coronary artery disease
G Ghiselli, A Gaddi, G Barozzi, A Ciarrocchi, G Descovich |
Metabolism | 1992 |
|
Assembly of plasmin-generating proteins on the surface of human endothelial cells
KA Hajjar |
Annals of Epidemiology | 1992 |
|
Postprandial lipoprotein (a) response to a single meal containing either saturated or ω-3 polyunsaturated fatty acids in subjects with hypoalphalipoproteinemia
AM Scanu, C Edelstein, GM Fless, J Eisenbart, M Sitrin, B Kasawa, J Hinman |
Metabolism | 1992 |
|
Plasma lipoprotein (a) protein concentration and coronary artery disease in black patients compared with white patients
MJ Sorrentino, C Vielhauer, JD Eisenbart, GM Fless, AM Scanu, T Feldman |
The American Journal of Medicine | 1992 |
|
Lipoprotein(a) interactions to several fibrinolytic factors and their plasma level changes due to age in healthy, coronary heart disease and stroke subjects
Y Jiao, J Monasterio, JF Li |
Fibrinolysis | 1992 |
|
Probucol protects lipoprotein(a) against oxidative modification
M Naruszewicz, E Selinger, R Dufour, J Davignon |
Metabolism | 1992 |
|
Expression and purification of kringle 4-type 2 of human apolipoprotein (a) in Escherichia coli
Z Li, R Gambino, GM Fless, RA Copeland, AJ Halfpenny, AM Scanu |
Protein Expression and Purification | 1992 |
|
Effects of fish oil on triglycerides, cholesterol, lipoprotein(a), atherogenic index and fibrinogen. Influence of degree of purification of the oil
O Haglund, R Luostarinen, R Wallin, T Saldeen |
Nutrition Research | 1992 |
|
Lack of association between lipoprotein (a) concentrations and coronary heart disease mortality in diabetes: The Wisconsin Epidemiologic Study of Diabetic Retinopathy
SM Haffner, SE Moss, BE Klein, R Klein |
Metabolism | 1992 |
|
Lipoprotein(a) link between structure and pathology
AM Scanu |
Annals of Epidemiology | 1992 |
|
An indirect sandwich ELISA for LP(a) in serum and dried blood spots
XL Wang, DE Wilcken, NP Dudman |
Clinica Chimica Acta | 1992 |
|
Multiple members of the plasminogen-apolipoprotein(a) gene family associated with thrombosis
A Ichinose |
Biochemistry | 1992 |
|
Apolipoprotein(a) and plasminogen interactions with fibrin: a study with recombinant apolipoprotein(a) and isolated plasminogen fragments
D Rouy, ML Koschinsky, V Fleury, J Chapman, E Angles-Cano |
Biochemistry | 1992 |
|
Management of Hypertension in Diabetes
C Arauz-Pacheco, P Raskin |
Endocrinology and metabolism clinics of North America | 1992 |
|
The biologic role of components of the plasminogen-plasmin system
HC Kwaan |
Progress in Cardiovascular Diseases | 1992 |
|
Atherogenesis in transgenic mice expressing human apolipoprotein(a)
RM Lawn, DP Wade, RE Hammer, G Chiesa, JG Verstuyft, EM Rubin |
Nature | 1992 |
|
Attenuation of immunologic reactivity of lipoprotein(a) by thiols and cysteine-containing compounds. Structural implications
AM Scanu, D Pfaffinger, GM Fless, K Makino, J Eisenbart, J Hinman |
Arteriosclerosis Thrombosis and Vascular Biology | 1992 |
|
Cardiac Dysfunction in Chronic Uremia
PS Parfrey, JD Harnett |
1992 | |
|
LP(A): A link between thrombosis and atherosclerosis
AM Scanu |
European Journal of Epidemiology | 1992 |
|
Cellular and Molecular Biology of Atherosclerosis
AM Gotto |
1992 | |
|
Reconstitution of lipoprotein(a) by infusion of human low density lipoprotein into transgenic mice expressing human apolipoprotein(a)
G Chiesa, HH Hobbs, ML Koschinsky, RM Lawn, SD Maika, RE Hammer |
The Journal of biological chemistry | 1992 |
|
Mechanisms by which lipoprotein lipase alters cellular metabolism of lipoprotein(a), low density lipoprotein, and nascent lipoproteins. Roles for low density lipoprotein receptors and heparan sulfate proteoglycans
KJ Williams, GM Fless, KA Petrie, ML Snyder, RW Brocia, TL Swenson |
The Journal of biological chemistry | 1992 |
|
Comparison of three methods of isolating lipoprotein (a) from human blood plasma
OI Afanas'eva, IY Adamova, GF Benevolenskaya, SN Pokrovskii |
Bulletin of Experimental Biology and Medicine | 1992 |
|
Organization of phosphatidylcholine and sphingomyelin in the surface monolayer of low density lipoprotein and lipoprotein(a) as determined by time-resolved fluorometry
A Sommer, E Prenner, R Gorges, H Stütz, H Grillhofer, GM Kostner, F Paltauf, A Hermetter |
The Journal of biological chemistry | 1992 |
|
Malondialdehyde modification of lipoprotein(a) produces avid uptake by human monocyte-macrophages
ME Haberland, GM Fless, AM Scanu, AM Fogelman |
The Journal of biological chemistry | 1992 |
|
Apolipoprotein genes and atherosclerosis
JL Breslow |
The Clinical Investigator | 1992 |
|
Lipoprotein(a): its inheritance and molecular basis of its atherothrombotic role
AM Scanu |
Molecular and Cellular Biochemistry | 1992 |
|
The apolipoprotein (a) gene: a transcribed hypervariable locus controlling plasma lipoprotein (a) concentration
HG Kraft, S Kchl, HJ Menzel, C Sandholzer, G Utermann |
Human Genetics | 1992 |
|
Effects of Treatment with Verapamil SR and Captopril on the Lipid Profile of Hypertensive Patients:
M Catalano, C Cislaghi, G Carzaniga, A Aronica, R Seregni, A Libretti |
Drugs | 1992 |
|
Interaction of recombinant apolipoprotein(a) and lipoprotein(a) with macrophages
TF Zioncheck, LM Powell, GC Rice, DL Eaton, RM Lawn |
Journal of Clinical Investigation | 1991 |
|
Molecular basis of apolipoprotein (a) isoform size heterogeneity as revealed by pulsed-field gel electrophoresis
C Lackner, E Boerwinkle, CC Leffert, T Rahmig, HH Hobbs |
Journal of Clinical Investigation | 1991 |
|
Role of oxidized low density lipoprotein in atherogenesis
JL Witztum, D Steinberg |
Journal of Clinical Investigation | 1991 |
|
Lipid abnormalities in renal disease
G Appel |
Kidney International | 1991 |
|
Apolipoprotein (a) levels in type 1 and type 2 diabetes mellitus
G Ruotolo, A Zoppo, M Parlavecchia, B Giberti, P Micossi |
Acta Diabetologica | 1991 |
|
Plasma lipoprotein distribution of apolipoprotein(a) in the fed and fasted states
JS Cohn, CW Lam, DR Sullivan, WJ Hensley |
Atherosclerosis | 1991 |
|
Lipoprotein(a): Nonhuman primate models
K Makino, AM Scanu |
Lipids | 1991 |
|
LP(a) as a marker for coronary heart disease risk
AM Scanu |
Clinical Cardiology | 1991 |
|
N-acetylcysteine and serum concentrations of lipoprotein(a)
AA Kroon, PN Demacker, AF Stalenhoef |
Journal of Internal Medicine | 1991 |
|
Lipoprotein (a) and Microvascular Disease in Type 1 (Insulin-dependent) Diabetes
PH Winocour, D Bhatnagar, M Ishola, S Arrol, PN Durrington |
Diabetic Medicine | 1991 |
|
Lipoprotein (a) inhibits the generation of transforming growth factor beta: an endogenous inhibitor of smooth muscle cell migration
S Kojima, PC Harpel, DB Rifkin |
The Journal of Cell Biology | 1991 |
|
A rapid increase in lipoprotein (a) levels after ethanol withdrawal in alcoholic men
K Kervinen, MJ Savolainen, YA Kesäniemi |
Life Sciences | 1991 |
|
Hypercholesterolaemia and vascular disease after transplantation
RM Higgins, PJ Ratcliffe |
Transplantation Reviews | 1991 |
|
Serum Lp(a) concentrations are unaffected by treatment with the HMG-CoA reductase inhibitor Pravastatin: results of a 2-year investigation
HG Fieseler, VW Armstrong, E Wieland, J Thiery, E Schütz, AK Walli, D Seidel |
Clinica Chimica Acta | 1991 |
|
Impaired fibrinolysis and risk of thromboembolism
B Wiman, A Hamsten |
Progress in Cardiovascular Diseases | 1991 |
|
Apolipoprotein(a): expression and characterization of a recombinant form of the protein in mammalian cells
ML Koschinsky, JE Tomlinson, TF Zioncheck, K Schwartz, DL Eaton, RM Lawn |
Biochemistry | 1991 |
|
Lipoprotein(a) impairs generation of plasmin by fibrin-bound tissue-type plasminogen activator. In vitro studies in a plasma milieu
D Rouy, P Grailhe, F Nigon, J Chapman, E Anglés-Cano |
Arteriosclerosis Thrombosis and Vascular Biology | 1991 |
|
Genetic Approaches to Coronary Heart Disease and Hypertension
K Berg, V Bulyzhenkov, Y Christen, P Corvol |
1991 | |
|
Diverse effect of ethnicity on plasma lipoprotein[a] levels in heterozygote patients with familial hypercholesterolemia
E Leitersdorf, Y Friedlander, JM Bard, JC Fruchart, S Eisenberg, Y Stein |
Journal of lipid research | 1991 |
|
Lipoprotein(a) mediates high affinity low density lipoprotein association to receptor negative fibroblasts
GM Kostner, HK Grillhofer |
The Journal of biological chemistry | 1991 |
|
The inhibition of tissue type plasminogen activator by plasminogen activator inhibitor-1. The effects of fibrinogen, heparin, vitronectin, and lipoprotein(a)
JM Edelberg, CF Reilly, SV Pizzo |
The Journal of biological chemistry | 1991 |
|
Relationship between apo[a] isoforms and Lp[a] density in subjects with different apo[a] phenotype: a study before and after a fatty meal
D Pfaffinger, J Schuelke, C Kim, GM Fless, AM Scanu |
Journal of lipid research | 1991 |
|
Contribution of the apo[a] phenotype to plasma Lp[a] concentrations shows considerable ethnic variation
M Helmhold, J Bigge, R Muche, J Mainoo, J Thiery, D Seidel, VW Armstrong |
Journal of lipid research | 1991 |
|
Effects of the apolipoprotein(a) size polymorphism on the lipoprotein(a) concentration in 7 ethnic groups
C Sandholzer, DM Hallman, N Saha, G Sigurdsson, C Lackner, A Csszr, E Boerwinkle, G Utermann |
Human Genetics | 1991 |
|
11 Lipoprotein(a)
AM Scanu |
Baillière's Clinical Endocrinology and Metabolism | 1990 |
Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)